Difficult diagnosis of Infliximab-related miliary tuberculosis

Submitted: February 29, 2016
Accepted: February 29, 2016
Published: June 30, 2004
Abstract Views: 422
PDF: 398
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The use of Infliximab in the treatment of patients with rheumatoid diseases unresponsive to conventional therapies has been reported to be complicated by opportunistic infections. We report the case of a 56-yr old female rheumatoid arthritis patient complaining of fever and respiratory symptoms 9 months after commencing Infliximab, who received no ethiologic diagnosis for the six months before admission. Tuberculosis was suspected upon chest radiographic pictures and empirical treatment for miliary tuberculosis instated in the wake of microbiological confirmation. The case typifies the difficulties of diagnosing miliary tuberculosis in the immunocompromised as well as in the immunocompetent patient.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Contini, S., G. Raimondi, P. Graziano, C. Saltini, and M. Bocchino. 2004. “Difficult Diagnosis of Infliximab-Related Miliary Tuberculosis”. Monaldi Archives for Chest Disease 61 (2). https://doi.org/10.4081/monaldi.2004.712.